StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
25
Publishing Date
2022 - 06 - 14
1
2022 - 01 - 31
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 01
1
2021 - 10 - 21
3
2021 - 10 - 04
2
2021 - 09 - 23
1
2021 - 09 - 09
1
2021 - 08 - 12
1
2021 - 06 - 09
1
2021 - 05 - 19
1
2021 - 04 - 28
1
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 11
1
2021 - 02 - 16
1
2021 - 02 - 09
1
2021 - 02 - 04
1
2021 - 02 - 03
1
2021 - 01 - 04
1
2020 - 12 - 15
1
Sector
Health technology
25
Manufacturing
2
Tags
Aav9
4
Acquisition
1
Approval
1
Bio-nc
5
Biomarkers
1
Ceo
1
Clinical-trials-phase-ii
1
Conference
3
Designation
2
Disease
2
Distribution
1
Earnings
1
Europe
2
Fast track
2
Fast track designation
2
Fda
2
Fda fast track
2
Fda-approvals
2
Financial
1
Financial results
4
Food
1
Gene therapies
24
Gene therapy
24
Market
1
Milestone
2
N/a
15
Ongoing
2
Parkinson
1
Pharm-country
5
Pharma
1
Phase 1
3
Phase 2
1
Phase 3
1
Positive
3
Presentation
1
Program
1
Research
1
Results
7
Svb leerink global
1
Therapy
25
Trial
2
Year
1
Entities
Abbott laboratories
22
Abbvie inc.
40
Abeona therapeutics inc.
21
Accuray incorporated
22
Actinium pharmaceuticals, inc.
16
Adaptimmune therapeutics plc
15
Amgen inc.
42
Anixa biosciences, inc.
16
Astellas pharma inc
23
Astrazeneca plc
32
Ati physical therapy inc - class a
38
Avrobio, inc.
23
Baxter international inc.
17
Biocardia, inc.
27
Biogen inc.
30
Biomarin pharmaceutical inc.
29
Biorestorative therapies, inc.
16
Bluebird bio, inc.
32
Brainsway ltd.
15
Bridgebio pharma, inc.
17
Bristol-myers squibb company
65
Celularity inc - class a
16
Charles river laboratories international, inc.
19
Crispr therapeutics ag
15
Eli lilly and company
88
Fate therapeutics, inc.
15
Fortress biotech, inc.
20
Genprex, inc.
29
Gilead sciences, inc.
52
Glaxosmithkline plc
24
Incyte corporation
37
Intellia therapeutics, inc.
17
Intra-cellular therapies inc.
33
Iovance biotherapeutics, inc.
15
Jaguar health, inc.
15
Johnson & johnson
103
Medtronic plc
30
Merck & company, inc.
31
Mustang bio, inc.
16
Neuronetics, inc.
35
Novartis ag
89
Ocugen, inc.
16
Orange
36
Orchard therapeutics plc
24
Pfizer, inc.
29
Poseida therapeutics, inc.
31
Precision biosciences, inc.
19
Regeneron pharmaceuticals, inc.
18
Regenxbio inc.
25
Rocket pharmaceuticals, inc.
16
Sanofi
113
Sarepta therapeutics, inc.
24
Sio gene therapies inc
25
Takeda pharmaceutical company limited
43
Taysha gene therapies, inc.
52
Thermo fisher scientific inc
26
Ultragenyx pharmaceutical inc.
18
Uniqure n.v.
36
Viewray, inc.
34
Voyager therapeutics, inc.
16
Symbols
ROIV
2
SIOX
25
Exchanges
Nasdaq
25
Crawled Date
2022 - 06 - 14
1
2022 - 01 - 31
1
2021 - 11 - 12
1
2021 - 11 - 11
1
2021 - 11 - 01
1
2021 - 10 - 21
3
2021 - 10 - 04
2
2021 - 09 - 23
1
2021 - 09 - 09
1
2021 - 08 - 12
1
2021 - 06 - 09
1
2021 - 05 - 19
1
2021 - 04 - 28
1
2021 - 03 - 29
1
2021 - 03 - 15
1
2021 - 03 - 11
1
2021 - 02 - 16
1
2021 - 02 - 09
1
2021 - 02 - 04
1
2021 - 02 - 03
1
2021 - 01 - 04
1
2020 - 12 - 15
1
Crawled Time
11:00
1
12:00
7
12:01
1
12:03
3
13:03
1
13:15
1
14:00
2
14:02
1
14:15
1
17:00
1
19:00
2
21:02
1
22:00
1
23:00
2
Source
www.biospace.com
13
www.globenewswire.com
12
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapy
entities :
Sio gene therapies inc
save search
Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
Published:
2022-06-14
(Crawled : 12:00)
- biospace.com/
ROIV
|
$10.36
-0.77%
-0.68%
3.4M
|
Manufacturing
|
196.59%
|
O:
1.42%
H:
8.68%
C:
4.62%
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
32.32%
|
O:
1.35%
H:
2.78%
C:
-1.39%
year
results
therapy
Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO Transition
Published:
2022-01-31
(Crawled : 23:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-56.07%
|
O:
-1.87%
H:
14.29%
C:
11.43%
gene therapy
program
ceo
gene therapies
therapy
Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial Results
Published:
2021-11-12
(Crawled : 23:00)
- biospace.com/
ROIV
|
$10.36
-0.77%
-0.68%
3.4M
|
Manufacturing
|
33.5%
|
O:
-0.38%
H:
9.11%
C:
7.83%
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-76.62%
|
O:
-4.48%
H:
4.17%
C:
3.65%
financial results
gene therapies
results
therapy
gene therapy
Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
Published:
2021-11-11
(Crawled : 14:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-75.65%
|
O:
2.07%
H:
2.54%
C:
2.03%
disease
gene therapies
gene therapy
therapy
parkinson
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 Gangliosidosis
Published:
2021-11-01
(Crawled : 19:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-75.39%
|
O:
0.0%
H:
6.28%
C:
6.28%
fda
fda fast track
gene therapies
fast track
gene therapy
therapy
fast track designation
designation
Sio Gene Therapies Announces Reorganization of R&D Group
Published:
2021-10-21
(Crawled : 22:00)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-80.08%
|
O:
-3.39%
H:
3.95%
C:
-11.4%
gene therapies
therapy
gene therapy
Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM1 (AAV9-GLB1) Gene Therapy in Patients with GM1 Gangliosidosis
Published:
2021-10-21
(Crawled : 17:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-78.14%
|
O:
9.3%
H:
12.98%
C:
0.43%
fda
fda fast track
gene therapies
fast track
gene therapy
therapy
aav9
fast track designation
designation
Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1 Gene Therapy in GM1 Gangliosidosis
Published:
2021-10-21
(Crawled : 11:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-78.14%
|
O:
9.3%
H:
12.98%
C:
0.43%
ongoing
gene therapies
phase 1
gene therapy
positive
therapy
biomarkers
UPDATE: Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published:
2021-10-04
(Crawled : 13:15)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-78.14%
|
O:
5.58%
H:
6.02%
C:
0.88%
europe
gene therapies
therapy
gene therapy
Sio Gene Therapies to Present New Data at the European Society of Gene and Cell Therapy Virtual Congress 2021
Published:
2021-10-04
(Crawled : 12:00)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-78.14%
|
O:
5.58%
H:
6.02%
C:
0.88%
europe
gene therapies
therapy
gene therapy
Sio Gene Therapies to Participate in Upcoming Conferences
Published:
2021-09-23
(Crawled : 12:00)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-79.74%
|
O:
0.0%
H:
3.02%
C:
2.59%
gene therapies
conference
therapy
gene therapy
Sio Gene Therapies Announces Dosing of First GM1 Gangliosidosis Early Infantile (Type I) Patient in Ongoing Phase 1/2 Study of AXO-AAV-GM1 Gene Therapy
Published:
2021-09-09
(Crawled : 19:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-77.4%
|
O:
0.0%
H:
9.13%
C:
6.25%
ongoing
gene therapies
phase 1
gene therapy
therapy
aav9
Sio Gene Therapies Announces Corporate Updates and Fiscal First Quarter 2021 Financial Results
Published:
2021-08-12
(Crawled : 12:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-75.9%
|
O:
1.54%
H:
4.04%
C:
3.03%
financial results
gene therapies
results
therapy
gene therapy
Sio Gene Therapies Announces Fiscal Year 2020 Year-End Financial Results and Expected Fiscal Year 2021 Key Milestones
Published:
2021-06-09
(Crawled : 12:00)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-79.39%
|
O:
1.14%
H:
7.98%
C:
4.51%
financial results
gene therapies
results
gene therapy
milestone
therapy
Sio Gene Therapies to Present at the UBS Global Healthcare Virtual Conference
Published:
2021-05-19
(Crawled : 14:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-79.11%
|
O:
-2.22%
H:
1.82%
C:
-0.45%
gene therapies
conference
therapy
gene therapy
Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy
Published:
2021-04-28
(Crawled : 14:15)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-81.64%
|
O:
0.78%
H:
8.14%
C:
3.88%
presentation
gene therapies
therapy
gene therapy
Sio Gene Therapies to Participate in Upcoming Conferences
Published:
2021-03-29
(Crawled : 12:00)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-81.5%
|
O:
-0.79%
H:
0.5%
C:
-0.4%
gene therapies
conference
therapy
gene therapy
Sio Gene Therapies Provides Update on Cash Position and Major Upcoming GM1 Gangliosidosis Program Milestones
Published:
2021-03-15
(Crawled : 12:00)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-83.33%
|
O:
0.71%
H:
3.52%
C:
-2.46%
gene therapies
positive
therapy
gene therapy
milestone
Sio Gene Therapies to Participate in Upcoming Investor & Scientific Conferences
Published:
2021-03-11
(Crawled : 14:02)
- biospace.com/
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-82.4%
|
O:
2.62%
H:
2.41%
C:
1.46%
gene therapies
therapy
gene therapy
Sio Gene Therapies to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Published:
2021-02-16
(Crawled : 12:03)
- globenewswire.com
SIOX
|
$0.478
-20.5%
40K
|
Health Technology
|
-85.8%
|
O:
0.3%
H:
3.92%
C:
-0.6%
gene therapies
svb leerink global
therapy
gene therapy
← Previous
1
2
Next →
Gainers vs Losers
60%
40%
Top 10 Gainers
AGBA
|
News
|
$1.03
157.5%
57.94%
120M
|
Finance
ZCMD
|
$1.45
5.84%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.52
100.0%
51.13%
5M
|
Health Technology
ISPC
|
$0.421
97.65%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.5
45.65%
470K
|
OST
|
$0.509
23.81%
45.26%
90K
|
GDHG
|
$0.263
21.76%
40.66%
3.1M
|
XPON
|
News
|
$3.15
63.21%
37.74%
16M
|
TIRX
|
$0.8
65.02%
30.74%
58M
|
BNTC
|
News
|
$6.82
42.08%
30.64%
3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.